FDA Enforcement in the Product Promotion and Advertising World: (A Little Late 2021) Year in Review and Issues to Consider for 2022
Please join AGG Food & Drug attorneys Alan G. Minsk and Laura S. Dona for a complimentary webinar reviewing past FDA letters issued to pharmaceutical and medical device companies for unlawful promotion in 2021 and where FDA might be headed in 2022.
During this webinar, Alan and Laura will:
- highlight some of the promotional concerns raised by FDA in 2021;
- examine letters to date in 2022; and
- offer recommendations, based on the attorneys’ experience sitting on Promotional Review Committees and advising companies in the space, to minimize risk.
There will be an opportunity for Q&A at the end of this webinar.
Credits: 1 hour of CLE credit is pending approval by the State Bar of Georgia.
Note: The presentation and audio for this webinar will be streamed through your computer. A dial-in number will not be provided.
To enhance your webinar experience with us, please make sure to close out of all other streaming services prior to joining the webinar. If you experience audio issues during the broadcast, hit the F5 button on your keyboard to refresh the webpage in your browser.
- Alan G. Minsk
- Laura S. Dona